Khondrion moves headquarters to Novio Tech Campus to support growth
Kadans Science Partner today welcomes Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial diseases, to its Building M at the Novio Tech Campus, a state-of-the-art health and life sciences research